You just read:

Merck KGaA, Darmstadt, Germany, Licenses Four Oncology Research and Development Programs from Vertex and Becomes a Leader in DNA Damage and Repair

News provided by

Merck KGaA, Darmstadt, Germany

Jan 11, 2017, 09:00 ET